Revolution Medicines, Inc. Common Stock
Symbol: RVMD (NASDAQ)
45.14
▲ (11.60%) 4.691
Company Description:
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Key Stats
- Today's Open: $42.9
- Today's High: $46.835
- Today's Low: $40.708
- Today's Volume: 2.92M
- Yesterday Close: $40.45
- Yesterday High: $41.08
- Yesterday Low: $39.73
- Yesterday Volume: 1.79M
- Last Min Volume: 3.99K
- Last Min High: $45.185
- Last Min Low: $45.155
- Last Min VWAP: $45.17293
Company Profile
- Name: Revolution Medicines, Inc. Common Stock
- Website: https://www.revmed.com
- Listed Date: 2020-02-13
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001628171
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $7.56B
- Round Lot: 100
- Outstanding Shares: 186.93M
- Asset Type: CS
RECENT FILINGS FOR RVMD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-02 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-27 | 8-K | View |
| 2025-06-24 | 8-K | View |
| 2025-06-23 | 4 | View |
Latest News on RVMD